India’s prohibition on exporting vaccines has contributed to delays in delivering shots to other parts of the world. India, the world’s largest drug producer, imposed the ban in May as it fell behind on domestic vaccination, but it said recently that with production expanding and its own inoculation program gaining speed, it would lift the embargo this month.
Covax is focusing on delivery of vaccines to countries that have so far vaccinated less than 10 percent of their population. In the Americas, that includes Jamaica, Nicaragua and Haiti.
With the Covax program faltering, the Pan American Health Organization has struck separate deals to buy millions of vaccine doses from China’s Sinopharm and Sinovac, as well as AstraZeneca. But those agreements still fall far short of meeting the need.
Around 37 percent of the population in Latin America and the Caribbean has been fully vaccinated, but access in the region has been very uneven; Cuba, Chile and Uruguay are among the most highly vaccinated countries in the world.
“We continue to urge countries with surplus doses to share these with countries in our region, where they can have life-saving impact,” said Dr. Carissa F. Etienne, director of the P.A.H.O.